# American Vanguard Corp: overview

AVD · NYSE · CIK 5981 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avd.md) · [Financials](/companies/avd/financials.md) · [Filings](/companies/avd/filings.md) · [Insiders](/companies/avd/insiders.md)

Latest reported revenue: [$116.8m](/filings/0001193125-26-342489.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-342489).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [118](/filings/0001193125-25-273381.md) | [166 d](/filings/0001193125-26-409138.md) | [116](/filings/0001193125-26-209203.md) | [129](/filings/0001193125-26-342489.md) | [119](/filings/0001193125-25-273381.md) | [151 d](/filings/0001193125-26-409138.md) | [124](/filings/0001193125-26-209203.md) | [117](/filings/0001193125-26-342489.md) |
| Gross margin | % | [14.6%](/filings/0001193125-25-273381.md) | [13.8% d](/filings/0001193125-26-409138.md) | [26.1%](/filings/0001193125-26-209203.md) | [31.4%](/filings/0001193125-26-342489.md) | [28.7%](/filings/0001193125-25-273381.md) | [28.3% d](/filings/0001193125-26-409138.md) | [31.1%](/filings/0001193125-26-209203.md) | [29.7%](/filings/0001193125-26-342489.md) |
| Operating margin | % | [(24.0%)](/filings/0001193125-25-273381.md) | [(42.3%) d](/filings/0001193125-26-409138.md) | [(3.7%)](/filings/0001193125-26-209203.md) | [3.4%](/filings/0001193125-26-342489.md) | [(5.5%)](/filings/0001193125-25-273381.md) | [(14.5%) d](/filings/0001193125-26-409138.md) | [1.5%](/filings/0001193125-26-209203.md) | [(0.3%)](/filings/0001193125-26-342489.md) |
| Net margin | % | [(21.8%)](/filings/0001193125-25-273381.md) | [(54.6%) d](/filings/0001193125-26-409138.md) | [(7.3%)](/filings/0001193125-26-209203.md) | [(0.7%)](/filings/0001193125-26-342489.md) | [(10.4%)](/filings/0001193125-25-273381.md) | [(18.7%) d](/filings/0001193125-26-409138.md) | [(3.4%)](/filings/0001193125-26-209203.md) | [(8.5%)](/filings/0001193125-26-342489.md) |
| Diluted EPS | $ per share | [(0.91)](/filings/0001193125-25-273381.md) | not reported | [(0.30)](/filings/0001193125-26-209203.md) | [(0.03)](/filings/0001193125-26-342489.md) | [(0.43)](/filings/0001193125-25-273381.md) | not reported | [(0.14)](/filings/0001193125-26-209203.md) | [(0.34)](/filings/0001193125-26-342489.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [558](/filings/0000950170-24-037524.md) | [610](/filings/0000950170-25-078615.md) | [579](/filings/0001193125-26-409138.md) | [547](/filings/0001193125-26-409138.md) | [515](/filings/0001193125-26-409138.md) |
| Gross margin | % | [30.6%](/filings/0000950170-24-037524.md) | [31.6%](/filings/0000950170-25-078615.md) | [30.9%](/filings/0001193125-26-409138.md) | [22.0%](/filings/0001193125-26-409138.md) | [28.6%](/filings/0001193125-26-409138.md) |
| Operating margin | % | [5.5%](/filings/0000950170-24-037524.md) | [6.7%](/filings/0000950170-25-078615.md) | [4.0%](/filings/0001193125-26-409138.md) | [(18.6%)](/filings/0001193125-26-409138.md) | [(5.5%)](/filings/0001193125-26-409138.md) |
| Net margin | % | [3.3%](/filings/0000950170-24-037524.md) | [4.5%](/filings/0000950170-25-078615.md) | [1.3%](/filings/0001193125-26-409138.md) | [(23.1%)](/filings/0001193125-26-409138.md) | [(9.7%)](/filings/0001193125-26-409138.md) |
| Diluted EPS | $ per share | [0.61](/filings/0000950170-24-037524.md) | [0.92](/filings/0000950170-25-078615.md) | [0.26](/filings/0001193125-26-409138.md) | [(4.50)](/filings/0001193125-26-409138.md) | [(1.75)](/filings/0001193125-26-409138.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/avd/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $4.8m | 1,723,002 |  | Added +68,107 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.2m | 1,148,010 |  | Added +7,266 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.6m | 933,473 |  | Reduced −1,145,430 |
| [EVR Research LP](/funds/1843019.md) | 2026-06-30 | $2.2m | 775,000 |  | Added +55,000 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $2.2m | 774,597 |  | Reduced −270,213 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $2.1m | 732,819 |  | Reduced −13,370 |
| [Cruiser Capital Advisors, LLC](/funds/1713506.md) | 2026-06-30 | $1.6m | 571,781 |  | Unchanged |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $1.5m | 530,006 |  | Added +26 |
| [CastleKnight Management LP](/funds/1835751.md) | 2026-06-30 | $1.4m | 504,333 |  | Unchanged |
| [RBF Capital, LLC](/funds/1134621.md) | 2026-06-30 | $1.2m | 418,583 |  | New +418,583 |

## Recent filings

[All 1,065 filings](/companies/avd/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 10:50 ET | [8-K](/filings/0001193125-26-409777.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-409777 |
| 2026-09-30 | 20:36 ET | [10-K/A](/filings/0001193125-26-409138.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-409138 |
| 2026-08-11 | 20:08 ET | [8-K](/filings/0001193125-26-344619.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-344619 |
| 2026-08-10 | 20:30 ET | [10-Q](/filings/0001193125-26-342489.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342489 |
| 2026-06-08 | 20:03 ET | [8-K](/filings/0001193125-26-261680.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-261680 |
| 2026-05-06 | 20:42 ET | [10-Q](/filings/0001193125-26-209203.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209203 |
| 2026-04-23 | 20:00 ET | [DEF 14A](/filings/0001193125-26-173620.md) | Proxy statement, period 2026-06-03 | 0001193125-26-173620 |
| 2026-04-15 | 20:22 ET | [8-K](/filings/0001193125-26-157085.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-157085 |
| 2026-03-19 | 10:01 ET | [8-K](/filings/0001193125-26-115049.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-115049 |
| 2026-03-18 | 21:00 ET | [8-K](/filings/0001193125-26-114235.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-114235 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-108593.md), filed Mar 16, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a935fc55-277e-40f2-81a4-e6a25d689cff)

## About the filer

- CIK: 5981
- Tickers: AVD
- Exchange: NYSE
- SIC code: 2870 Agricultural Chemicals
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.